Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

MGRX

Mangoceuticals (MGRX)

Mangoceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:MGRX
日付受信時刻ニュースソース見出しコード企業名
2024/06/1903 : 57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
2024/06/1102 : 28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
2024/06/0621 : 30GlobeNewswire Inc.MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care TechnologyNASDAQ:MGRXMangoceuticals Inc
2024/06/0606 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
2024/06/0606 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGRXMangoceuticals Inc
2024/06/0606 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGRXMangoceuticals Inc
2024/06/0505 : 00GlobeNewswire Inc.MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont TechnologiesNASDAQ:MGRXMangoceuticals Inc
2024/06/0421 : 00GlobeNewswire Inc.MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone ImbalancesNASDAQ:MGRXMangoceuticals Inc
2024/05/2821 : 30GlobeNewswire Inc.Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American MarketsNASDAQ:MGRXMangoceuticals Inc
2024/05/2321 : 30GlobeNewswire Inc.MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing EffortsNASDAQ:MGRXMangoceuticals Inc
2024/05/2121 : 30GlobeNewswire Inc.MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 MedicationsNASDAQ:MGRXMangoceuticals Inc
2024/05/1705 : 40GlobeNewswire Inc.MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market PenetrationNASDAQ:MGRXMangoceuticals Inc
2024/05/1702 : 59Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGRXMangoceuticals Inc
2024/05/1622 : 19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGRXMangoceuticals Inc
2024/05/1605 : 52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGRXMangoceuticals Inc
2024/05/1422 : 00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGRXMangoceuticals Inc
2024/05/1013 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGRXMangoceuticals Inc
2024/05/0706 : 32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGRXMangoceuticals Inc
2024/05/0705 : 43Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MGRXMangoceuticals Inc
2024/05/0221 : 00GlobeNewswire Inc.Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity RequirementNASDAQ:MGRXMangoceuticals Inc
2024/04/2521 : 30GlobeNewswire Inc.Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive CareNASDAQ:MGRXMangoceuticals Inc
2024/04/1221 : 45GlobeNewswire Inc.Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) ProductsNASDAQ:MGRXMangoceuticals Inc
2024/03/1222 : 00GlobeNewswire Inc.MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) TreatmentNASDAQ:MGRXMangoceuticals Inc
2024/02/2023 : 00GlobeNewswire Inc.MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue GrowthNASDAQ:MGRXMangoceuticals Inc
2024/02/1322 : 00GlobeNewswire Inc.MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITYNASDAQ:MGRXMangoceuticals Inc
2024/02/0623 : 00GlobeNewswire Inc.MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITSNASDAQ:MGRXMangoceuticals Inc
2024/02/0522 : 50GlobeNewswire Inc.MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) ProductNASDAQ:MGRXMangoceuticals Inc
2024/01/1922 : 00GlobeNewswire Inc.MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11NASDAQ:MGRXMangoceuticals Inc
2023/12/1600 : 39GlobeNewswire Inc.Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public OfferingNASDAQ:MGRXMangoceuticals Inc
2023/12/1321 : 30GlobeNewswire Inc.MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCTNASDAQ:MGRXMangoceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MGRX